{"hands_on_practices": [{"introduction": "To fully appreciate the formidable infectivity of the measles virus, it is essential to move beyond qualitative descriptions and engage with quantitative models of transmission. This exercise introduces the Wells-Riley model, a foundational tool in public health for estimating the risk of airborne infection in indoor spaces. By working through the derivation, you will gain a hands-on understanding of how factors like room volume, ventilation rate, and viral emission rate collectively determine the probability of transmission, providing a concrete framework for evaluating infection control strategies [@problem_id:4648227].", "problem": "A closed, mechanically ventilated classroom is occupied by a single measles case for a continuous period of $T = 1$ hour. Assume the room air is well mixed, the initial airborne infectious quanta concentration at $t=0$ is zero, and the only removal pathway is ventilation. The following scenario is scientifically consistent with measles transmission via aerosolized quanta:\n\n- One infectious source emits measles infectious quanta at a constant rate $q$ (quanta per hour).\n- The room has volume $V$ (cubic meters) and a constant ventilation rate of $\\lambda$ air changes per hour (Air Changes per Hour (ACH)).\n- A susceptible occupant inhales air at a constant volumetric breathing rate $p$ (cubic meters per hour).\n- A fraction $\\alpha$ of all occupants are immunologically susceptible to measles (the remainder are immune). Consider the probability that a randomly selected occupant becomes infected during the $T$-hour exposure.\n\nUse as fundamental bases:\n- The quanta concept: a single quantum inhaled confers a mean probability of infection of one event; infection follows a Poisson process with mean equal to the expected number of inhaled quanta.\n- Poisson event statistics: for a Poisson process with mean $\\mu$, the probability of zero events is $\\exp(-\\mu)$, so the probability of one or more events is $1 - \\exp(-\\mu)$.\n- A well-mixed mass balance for airborne concentration $C(t)$ (quanta per cubic meter) with source and first-order removal: $\\frac{dC}{dt} = \\frac{I q}{V} - \\lambda C(t)$ for $I$ infectious individuals.\n\nParameters for this classroom:\n- $I = 1$\n- $q = 300$ quanta per hour\n- $V = 150$ cubic meters\n- $\\lambda = 3$ per hour\n- $p = 0.5$ cubic meters per hour\n- $\\alpha = 0.10$\n- $T = 1$ hour\n\nDerive from the stated bases an analytic expression for the infection probability of a randomly selected occupant after $T$ hours, then compute its numerical value using the given parameters. Express the final probability as a decimal. Round your answer to three significant figures. No angle units are involved; no physical units should be included with the final probability.", "solution": "The problem is valid as it is scientifically grounded in the Wells-Riley model of airborne disease transmission, is mathematically well-posed with a complete set of parameters and a clear objective, and is free of any inconsistencies or ambiguities.\n\nThe solution proceeds by first deriving an analytical expression for the infection probability and then computing its numerical value.\n\nThe concentration of infectious quanta, $C(t)$, in the room air is governed by the mass balance differential equation:\n$$ \\frac{dC}{dt} = \\frac{I q}{V} - \\lambda C(t) $$\nwhere $I$ is the number of infectious individuals, $q$ is the quanta generation rate, $V$ is the room volume, and $\\lambda$ is the air change rate. The initial condition is that the concentration is zero at time $t=0$, i.e., $C(0)=0$.\n\nThis is a first-order linear ordinary differential equation. We can rewrite it in standard form:\n$$ \\frac{dC}{dt} + \\lambda C(t) = \\frac{I q}{V} $$\nThe integrating factor is $\\exp(\\int \\lambda dt) = \\exp(\\lambda t)$. Multiplying the equation by the integrating factor yields:\n$$ \\exp(\\lambda t) \\frac{dC}{dt} + \\lambda \\exp(\\lambda t) C(t) = \\frac{I q}{V} \\exp(\\lambda t) $$\nThe left side is the derivative of a product:\n$$ \\frac{d}{dt} \\left( C(t) \\exp(\\lambda t) \\right) = \\frac{I q}{V} \\exp(\\lambda t) $$\nIntegrating both sides with respect to time $t$:\n$$ C(t) \\exp(\\lambda t) = \\int \\frac{I q}{V} \\exp(\\lambda t) dt = \\frac{I q}{V \\lambda} \\exp(\\lambda t) + K $$\nwhere $K$ is the constant of integration. We solve for $C(t)$:\n$$ C(t) = \\frac{I q}{V \\lambda} + K \\exp(-\\lambda t) $$\nUsing the initial condition $C(0)=0$:\n$$ 0 = \\frac{I q}{V \\lambda} + K \\exp(0) \\implies K = -\\frac{I q}{V \\lambda} $$\nSubstituting $K$ back gives the time-dependent concentration of infectious quanta:\n$$ C(t) = \\frac{I q}{V \\lambda} \\left( 1 - \\exp(-\\lambda t) \\right) $$\n\nA susceptible occupant inhales air at a volumetric rate $p$. The rate of inhaling quanta is $p C(t)$. The total number of quanta inhaled over the exposure period from $t=0$ to $t=T$ is the mean $\\mu$ of the Poisson distribution for infection events. This is calculated by integrating the inhalation rate over time:\n$$ \\mu = \\int_{0}^{T} p C(t) dt = \\int_{0}^{T} p \\left( \\frac{I q}{V \\lambda} (1 - \\exp(-\\lambda t)) \\right) dt $$\nSince $p$, $I$, $q$, $V$, and $\\lambda$ are constants, we have:\n$$ \\mu = \\frac{p I q}{V \\lambda} \\int_{0}^{T} (1 - \\exp(-\\lambda t)) dt $$\nEvaluating the integral:\n$$ \\int_{0}^{T} (1 - \\exp(-\\lambda t)) dt = \\left[ t + \\frac{1}{\\lambda} \\exp(-\\lambda t) \\right]_{0}^{T} $$\n$$ = \\left( T + \\frac{1}{\\lambda} \\exp(-\\lambda T) \\right) - \\left( 0 + \\frac{1}{\\lambda} \\exp(0) \\right) = T - \\frac{1}{\\lambda} (1 - \\exp(-\\lambda T)) $$\nTherefore, the mean number of inhaled quanta is:\n$$ \\mu = \\frac{p I q}{V \\lambda} \\left[ T - \\frac{1}{\\lambda} (1 - \\exp(-\\lambda T)) \\right] $$\n\nAccording to the Poisson model, the probability of infection for a susceptible individual who has inhaled a mean of $\\mu$ quanta is the probability of one or more events, which is $1$ minus the probability of zero events:\n$$ P_{\\text{inf|susceptible}} = 1 - P(0) = 1 - \\exp(-\\mu) $$\n\nThe problem asks for the infection probability of a randomly selected occupant. A fraction $\\alpha$ of occupants are susceptible. The remaining fraction $(1-\\alpha)$ is immune, with an infection probability of $0$. Using the law of total probability:\n$$ P_{\\text{inf}} = P_{\\text{inf|susceptible}} \\times \\alpha + P_{\\text{inf|immune}} \\times (1-\\alpha) $$\n$$ P_{\\text{inf}} = (1 - \\exp(-\\mu)) \\times \\alpha + 0 \\times (1-\\alpha) = \\alpha (1 - \\exp(-\\mu)) $$\nSubstituting the expression for $\\mu$, the final analytical expression for the infection probability is:\n$$ P_{\\text{inf}} = \\alpha \\left( 1 - \\exp\\left( -\\frac{p I q}{V \\lambda} \\left[ T - \\frac{1}{\\lambda} (1 - \\exp(-\\lambda T)) \\right] \\right) \\right) $$\n\nNow, we substitute the given numerical values:\n- $I = 1$\n- $q = 300$ quanta/hour\n- $V = 150 \\text{ m}^3$\n- $\\lambda = 3 \\text{ hr}^{-1}$\n- $p = 0.5 \\text{ m}^3/\\text{hr}$\n- $\\alpha = 0.10$\n- $T = 1 \\text{ hr}$\n\nFirst, we calculate the terms required for $\\mu$. The pre-factor is:\n$$ \\frac{p I q}{V \\lambda} = \\frac{(0.5)(1)(300)}{(150)(3)} = \\frac{150}{450} = \\frac{1}{3} $$\nThe time-dependent term in brackets is:\n$$ T - \\frac{1}{\\lambda} (1 - \\exp(-\\lambda T)) = 1 - \\frac{1}{3} (1 - \\exp(-3 \\times 1)) = 1 - \\frac{1}{3} (1 - \\exp(-3)) $$\nNow we compute $\\mu$:\n$$ \\mu = \\frac{1}{3} \\left[ 1 - \\frac{1}{3} (1 - \\exp(-3)) \\right] = \\frac{1}{3} - \\frac{1}{9} + \\frac{1}{9}\\exp(-3) = \\frac{2}{9} + \\frac{1}{9}\\exp(-3) = \\frac{1}{9} (2 + \\exp(-3)) $$\nUsing the value $\\exp(-3) \\approx 0.049787$:\n$$ \\mu \\approx \\frac{1}{9} (2 + 0.049787) = \\frac{2.049787}{9} \\approx 0.227754 $$\nThe probability of infection for a susceptible individual is:\n$$ P_{\\text{inf|susceptible}} = 1 - \\exp(-\\mu) \\approx 1 - \\exp(-0.227754) \\approx 1 - 0.796323 \\approx 0.203677 $$\nFinally, the probability of infection for a randomly selected occupant is:\n$$ P_{\\text{inf}} = \\alpha \\times P_{\\text{inf|susceptible}} \\approx 0.10 \\times 0.203677 = 0.0203677 $$\nRounding to three significant figures, we get $0.0204$.", "answer": "$$ \\boxed{0.0204} $$", "id": "4648227"}, {"introduction": "While vaccination has dramatically reduced their incidence, measles and mumps have not been eradicated and can cause severe, life-threatening complications. This practice shifts the focus from transmission dynamics to clinical outcomes, demonstrating how to quantify the risk of serious complications like encephalitis. By applying fundamental principles of probability to epidemiological data, you will learn to calculate and compare the risks associated with each disease, translating attack rates and incidence data into meaningful metrics for public health assessment and patient counseling [@problem_id:4648239].", "problem": "A residential university cohort of size $N$ experiences contemporaneous outbreaks of measles and mumps over a single academic term. Surveillance reports from a comparable setting indicate that acute encephalitis complicates measles cases at a rate of $1$ per $1{,}000$ reported measles cases, and mumps cases at a rate of $1$ per $6{,}000$ reported mumps cases. Over the term, epidemiologic investigation in this cohort estimates an attack rate of $0.14$ for measles and $0.04$ for mumps. Assume the cohort is well-mixed, these attack rates are measured over the same time window, encephalitis occurs only as a complication of clinical infection by the corresponding virus, and co-infections are negligible for the purpose of expectation.\n\nUsing only standard definitions from probability and infectious disease epidemiology (attack rate as the proportion becoming cases during the specified period; complication incidence among cases as the conditional probability of the complication given case status), compute the following, in order:\n\n- The ratio of encephalitis risk per case in measles compared to mumps.\n- The per-person risk in this cohort of developing encephalitis attributable to measles during the term.\n- The per-person risk in this cohort of developing encephalitis attributable to mumps during the term.\n- The expected number of encephalitis cases in the cohort due to measles, as a function of $N$.\n- The expected number of encephalitis cases in the cohort due to mumps, as a function of $N$.\n\nExpress all five answers exactly, without rounding, and present them as a single row vector. Do not include any units.", "solution": "The problem asks for the computation of five quantities related to outbreaks of measles and mumps in a university cohort of size $N$. We begin by formalizing the provided information using standard probabilistic notation.\n\nLet $M$ be the event that a randomly selected individual from the cohort contracts measles, and let $Mu$ be the event that this individual contracts mumps. Let $E_M$ be the event that the individual develops encephalitis as a complication of measles, and $E_{Mu}$ be the event that the individual develops encephalitis as a complication of mumps.\n\nThe problem provides the following data:\n- The attack rate for measles is $0.14$. In probabilistic terms, this is the probability of contracting measles for any given individual: $P(M) = 0.14$.\n- The attack rate for mumps is $0.04$. This is the probability of contracting mumps: $P(Mu) = 0.04$.\n- The rate of acute encephalitis in measles cases is $1$ per $1,000$. This is the conditional probability of developing encephalitis from measles, given that one has measles: $P(E_M | M) = \\frac{1}{1000}$.\n- The rate of acute encephalitis in mumps cases is $1$ per $6,000$. This is the conditional probability of developing encephalitis from mumps, given that one has mumps: $P(E_{Mu} | Mu) = \\frac{1}{6000}$.\n- The size of the cohort is $N$.\n\nThe problem states that encephalitis occurs only as a complication of the corresponding viral infection. This implies that the probability of developing measles-attributable encephalitis without having measles is zero, i.e., $P(E_M | \\neg M) = 0$, where $\\neg M$ is the event of not having measles. A similar condition holds for mumps: $P(E_{Mu} | \\neg Mu) = 0$.\n\nWe will now compute the five requested quantities in order.\n\n1.  **The ratio of encephalitis risk per case in measles compared to mumps.**\nThis is the ratio of the conditional probability of encephalitis given measles to the conditional probability of encephalitis given mumps.\n$$ \\text{Ratio} = \\frac{P(E_M | M)}{P(E_{Mu} | Mu)} $$\nSubstituting the given values:\n$$ \\text{Ratio} = \\frac{1/1000}{1/6000} = \\frac{1}{1000} \\cdot \\frac{6000}{1} = \\frac{6000}{1000} = 6 $$\nThe first answer is $6$.\n\n2.  **The per-person risk in this cohort of developing encephalitis attributable to measles during the term.**\nThis quantity is the marginal probability of developing encephalitis from measles, $P(E_M)$. Using the law of total probability:\n$$ P(E_M) = P(E_M | M)P(M) + P(E_M | \\neg M)P(\\neg M) $$\nGiven that $P(E_M | \\neg M) = 0$, the expression simplifies to:\n$$ P(E_M) = P(E_M | M)P(M) $$\nSubstituting the given values and expressing them as exact fractions:\n$$ P(M) = 0.14 = \\frac{14}{100} = \\frac{7}{50} $$\n$$ P(E_M) = \\left(\\frac{1}{1000}\\right) \\times \\left(\\frac{7}{50}\\right) = \\frac{7}{50000} $$\nThe second answer is $\\frac{7}{50000}$.\n\n3.  **The per-person risk in this cohort of developing encephalitis attributable to mumps during the term.**\nThis calculation is analogous to the one for measles. We seek the marginal probability $P(E_{Mu})$.\n$$ P(E_{Mu}) = P(E_{Mu} | Mu)P(Mu) + P(E_{Mu} | \\neg Mu)P(\\neg Mu) $$\nWith $P(E_{Mu} | \\neg Mu) = 0$, this simplifies to:\n$$ P(E_{Mu}) = P(E_{Mu} | Mu)P(Mu) $$\nSubstituting the given values:\n$$ P(Mu) = 0.04 = \\frac{4}{100} = \\frac{1}{25} $$\n$$ P(E_{Mu}) = \\left(\\frac{1}{6000}\\right) \\times \\left(\\frac{1}{25}\\right) = \\frac{1}{150000} $$\nThe third answer is $\\frac{1}{150000}$.\n\n4.  **The expected number of encephalitis cases in the cohort due to measles, as a function of $N$.**\nLet $X_M$ be the number of individuals in the cohort of size $N$ who develop encephalitis due to measles. This can be viewed as the sum of $N$ independent Bernoulli trials, where the probability of success (an individual developing measles-attributable encephalitis) is $p_M = P(E_M) = \\frac{7}{50000}$. The random variable $X_M$ thus follows a binomial distribution, $X_M \\sim \\text{Binomial}(N, p_M)$. The expectation of a binomial random variable is $E[X] = np$.\n$$ E[X_M] = N \\times p_M = N \\times \\frac{7}{50000} = \\frac{7N}{50000} $$\nThe fourth answer is $\\frac{7N}{50000}$.\n\n5.  **The expected number of encephalitis cases in the cohort due to mumps, as a function of $N$.**\nSimilarly, let $X_{Mu}$ be the number of cases of mumps-attributable encephalitis in the cohort. The probability for any individual is $p_{Mu} = P(E_{Mu}) = \\frac{1}{150000}$. The expected number of cases is:\n$$ E[X_{Mu}] = N \\times p_{Mu} = N \\times \\frac{1}{150000} = \\frac{N}{150000} $$\nThe fifth answer is $\\frac{N}{150000}$.", "answer": "$$\n\\boxed{\\begin{pmatrix} 6 & \\frac{7}{50000} & \\frac{1}{150000} & \\frac{7N}{50000} & \\frac{N}{150000} \\end{pmatrix}}\n$$", "id": "4648239"}, {"introduction": "In an era of widespread vaccination, diagnosing measles presents a unique challenge, as breakthrough infections can occur and symptoms may overlap with other illnesses. This practice explores the critical intersection of clinical diagnostics and statistics, focusing on the interpretation of laboratory results. You will design a diagnostic algorithm using combined serological and molecular tests and, most importantly, calculate its Positive Predictive Value (PPV). This exercise illuminates why the reliability of a positive test result depends heavily on the disease's prevalence and the tests' characteristics, a cornerstone concept of evidence-based medicine [@problem_id:4648290].", "problem": "A vaccinated adult presents with fever, cough, coryza, conjunctivitis, and a maculopapular rash beginning on the face and spreading cephalocaudally. To reduce false positive measles assignments in the context of prior immunization, design a diagnostic algorithm that integrates laboratory tests with timing of specimen collection and explicit decision rules, and then quantify the probability that a patient truly has measles when the composite decision rule is positive.\n\nUse the following context and constraints to construct the algorithm:\n- Collect a serum sample and a respiratory specimen (oropharyngeal swab) within $3$ days of rash onset.\n- Order measles virus immunoglobulin M (IgM) by enzyme-linked immunosorbent assay (ELISA) on serum and measles virus detection by Reverse Transcription Polymerase Chain Reaction (RT-PCR) on the swab.\n- Define a composite rule for \"laboratory-confirmed measles\" as: call the result positive only if both IgM and RT-PCR are positive on the same visit; call the result negative only if both are negative; treat discordant results as indeterminate and manage with repeat testing or convalescent immunoglobulin G (IgG) avidity at $10$â€“$14$ days, which is outside the scope of the following calculation.\n\nStarting from the core definitions that sensitivity is $P(T^{+}\\,|\\,D)$, specificity is $P(T^{-}\\,|\\,\\neg D)$, and that Positive Predictive Value (PPV) is $P(D\\,|\\,\\text{positive decision})$, and using the laws of conditional probability, derive an analytic expression for the PPV of the above composite decision rule under the assumption that, conditional on true disease status, IgM and RT-PCR results are independent. Then evaluate it numerically for the following plausible values in a vaccinated, symptomatic population meeting a clinical case definition:\n- Prevalence $p = 0.008$.\n- IgM sensitivity $S_{1} = 0.82$, IgM specificity $C_{1} = 0.95$.\n- RT-PCR sensitivity $S_{2} = 0.92$, RT-PCR specificity $C_{2} = 0.995$.\n\nExpress the final PPV as a decimal, and round your answer to four significant figures.", "solution": "The problem statement is evaluated as valid. It is scientifically grounded in established principles of clinical epidemiology and microbiology, is mathematically well-posed, and provides a complete and consistent set of data and definitions to derive a unique solution. The scenario is clinically relevant and the parameter values are plausible.\n\nLet $D$ be the event that the patient has measles, and $\\neg D$ be the event that the patient does not have measles. The prevalence of the disease is given as $p$, so $P(D) = p$. Consequently, $P(\\neg D) = 1 - p$.\n\nLet $T_1$ denote the result of the immunoglobulin M (IgM) test and $T_2$ denote the result of the Reverse Transcription Polymerase Chain Reaction (RT-PCR) test. A positive result is denoted by a superscript '$+$' and a negative result by a superscript '$-$'.\n\nThe performance characteristics of the individual tests are given as:\n- IgM sensitivity: $S_1 = P(T_1^+ \\,|\\, D) = 0.82$\n- IgM specificity: $C_1 = P(T_1^- \\,|\\, \\neg D) = 0.95$\n- RT-PCR sensitivity: $S_2 = P(T_2^+ \\,|\\, D) = 0.92$\n- RT-PCR specificity: $C_2 = P(T_2^- \\,|\\, \\neg D) = 0.995$\n\nFrom the specificities, we can determine the false positive rates for each test:\n- IgM false positive rate: $P(T_1^+ \\,|\\, \\neg D) = 1 - P(T_1^- \\,|\\, \\neg D) = 1 - C_1$\n- RT-PCR false positive rate: $P(T_2^+ \\,|\\, \\neg D) = 1 - P(T_2^- \\,|\\, \\neg D) = 1 - C_2$\n\nThe problem defines a composite decision rule for a \"laboratory-confirmed\" positive result, which we will denote as $T_C^+$. This event occurs if and only if both the IgM test and the RT-PCR test are positive. Therefore, the composite positive event is the intersection of the individual positive test events:\n$$T_C^+ = T_1^+ \\cap T_2^+$$\n\nThe objective is to derive an analytic expression for the Positive Predictive Value (PPV) of this composite rule, denoted $PPV_C$, and then calculate its numerical value. The PPV is defined as the probability that a patient truly has the disease given that the composite test is positive:\n$$PPV_C = P(D \\,|\\, T_C^+)$$\n\nUsing Bayes' theorem, we can express the $PPV_C$ as:\n$$PPV_C = \\frac{P(T_C^+ \\,|\\, D) P(D)}{P(T_C^+)}$$\n\nThe term $P(T_C^+ \\,|\\, D)$ is the sensitivity of the composite test, $S_C$. It is the probability of the composite test being positive given that the patient has the disease.\n$$S_C = P(T_C^+ \\,|\\, D) = P(T_1^+ \\cap T_2^+ \\,|\\, D)$$\nThe problem states that we must assume the test results are independent, conditional on the true disease status. This means:\n$$P(T_1^+ \\cap T_2^+ \\,|\\, D) = P(T_1^+ \\,|\\, D) P(T_2^+ \\,|\\, D) = S_1 S_2$$\n\nThe denominator, $P(T_C^+)$, is the total probability of obtaining a positive result from the composite rule. We can expand this using the law of total probability:\n$$P(T_C^+) = P(T_C^+ \\,|\\, D) P(D) + P(T_C^+ \\,|\\, \\neg D) P(\\neg D)$$\nWe have already determined the first part of this sum: $P(T_C^+ \\,|\\, D) P(D) = S_C p = S_1 S_2 p$.\n\nThe second part, $P(T_C^+ \\,|\\, \\neg D)$, represents the probability of a positive composite result in a patient without the disease (i.e., a composite false positive).\n$$P(T_C^+ \\,|\\, \\neg D) = P(T_1^+ \\cap T_2^+ \\,|\\, \\neg D)$$\nAgain, applying the conditional independence assumption:\n$$P(T_1^+ \\cap T_2^+ \\,|\\, \\neg D) = P(T_1^+ \\,|\\, \\neg D) P(T_2^+ \\,|\\, \\neg D) = (1 - C_1)(1 - C_2)$$\nThis term can be interpreted as $1 - C_C$, where $C_C$ is the specificity of the composite rule.\n\nNow we can write the full expression for the denominator:\n$$P(T_C^+) = (S_1 S_2) p + (1 - C_1)(1 - C_2)(1 - p)$$\n\nSubstituting the expressions for the numerator and denominator back into the Bayes' theorem formula for $PPV_C$, we an obtain the final analytic expression:\n$$PPV_C = \\frac{S_1 S_2 p}{S_1 S_2 p + (1 - C_1)(1 - C_2)(1 - p)}$$\n\nNow, we evaluate this expression numerically using the provided values:\n- $p = 0.008$\n- $S_1 = 0.82$\n- $C_1 = 0.95$\n- $S_2 = 0.92$\n- $C_2 = 0.995$\n\nFirst, calculate the composite sensitivity and the composite false positive rate:\n- Composite sensitivity: $S_C = S_1 S_2 = 0.82 \\times 0.92 = 0.7544$\n- Composite false positive rate: $(1 - C_1)(1 - C_2) = (1 - 0.95)(1 - 0.995) = 0.05 \\times 0.005 = 0.00025$\n\nNext, calculate the terms in the $PPV_C$ formula:\n- Numerator (True Positives): $S_C p = 0.7544 \\times 0.008 = 0.0060352$\n- Denominator, first term (True Positives): $S_C p = 0.0060352$\n- Denominator, second term (False Positives): $(1 - C_1)(1 - C_2)(1 - p) = 0.00025 \\times (1 - 0.008) = 0.00025 \\times 0.992 = 0.000248$\n\nNow, calculate the total probability of a positive composite test:\n- $P(T_C^+) = 0.0060352 + 0.000248 = 0.0062832$\n\nFinally, calculate the $PPV_C$:\n$$PPV_C = \\frac{0.0060352}{0.0062832} \\approx 0.960525448...$$\n\nThe problem requires the final answer to be expressed as a decimal rounded to four significant figures.\nRounding $0.960525448...$ to four significant figures gives $0.9605$.", "answer": "$$\\boxed{0.9605}$$", "id": "4648290"}]}